Trisodium;2-[2-[carboxylatomethyl-[[3-hydroxy-2-methyl-5-(phosphonatooxymethyl)pyridin-1-ium-4-yl]methyl]amino]ethyl-[[3-hydroxy-5-[[hydroxy(oxido)phosphoryl]oxymethyl]-2-methylpyridin-1-ium-4-yl]methyl]amino]acetate;manganese
(NBHBBGSKOXRZSD-UHFFFAOYSA-K)
Structure
- SMILES
- [O-]C(=O)CN(Cc1c(c[nH+]c(c1O)C)COP(=O)([O-])[O-])CCN(Cc1c(c[nH+]c(c1O)C)COP(=O)(O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Mn]
- Molecular Formula:
- C22H29MnN4Na3O14P2
- Molecular Weight:
- 759.339
- Log P:
- -2.3200
- Hydrogen Bond Acceptor:
- 16
- Hydrogen Bond Donor:
- 5
- TPSA:
- 317.11
- CAS Number(s):
- N/A
Synonym(s)
1.
Trisodium;2-[2-[carboxylatomethyl-[[3-hydroxy-2-methyl-5-(phosphonatooxymethyl)pyridin-1-ium-4-yl]methyl]amino]ethyl-[[3-hydroxy-5-[[hydroxy(oxido)phosphoryl]oxymethyl]-2-methylpyridin-1-ium-4-yl]methyl]amino]acetate;manganese
2.
Teslascan
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal Pain | SIDER | ||
| 2 | Chest Pain | SIDER | ||
| 3 | Dermatitis | SIDER | ||
| 4 | Discomfort | SIDER | ||
| 5 | Dizziness | SIDER | ||
| 6 | Dysgeusia | SIDER | ||
| 7 | Flushing | SIDER | ||
| 8 | Gastrointestinal Pain | SIDER | ||
| 9 | Headache | SIDER | ||
| 10 | Hypersensitivity | SIDER | ||
| 11 | Injection site discomfort | SIDER | ||
| 12 | Nausea | SIDER | ||
| 13 | Pain | SIDER | ||
| 14 | Palpitations | SIDER | ||
| 15 | Pneumonia | SIDER | ||
| 16 | Pruritus | SIDER | ||
| 17 | Sepsis | SIDER | ||
| 18 | Urticaria | SIDER | ||
| 19 | Vomiting | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.